Diagnostic Histopathology
Volume 15, Issue 10 , Pages 478-484, October 2009

Overview of recommendations of HER2 testing in breast cancer

Elena Provenzano MB BS PhD FRCPA is the Lead Breast Pathologist at the Department of Histopathology, and NIHR Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK

Nicola Johnson BSc FIBMS PhD is Senior Biomedical Scientist incharge of the HER2 Testing Service at the Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK

published online 21 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1756-2317(09)00144-3

doi:10.1016/j.mpdhp.2009.07.006

Diagnostic Histopathology
Volume 15, Issue 10 , Pages 478-484, October 2009

Article Tools

* Image Usage & Resolution